Works by Paszkiewicz‐Kozik, E.

Results: 19

Presence of t(14;18) positive cells in blood and bone marrow does not predict outcome in follicular lymphoma.

Published in:

Medical Oncology, 2009, v. 26, n. 1, p. 16, doi. 10.1007/s12032-008-9071-1

By:

E. Paszkiewicz-Kozik;
J. Kulik;
A. Fabisiewicz;
A. Tysarowski;
E. Kraszewska;
J. Siedlecki;
J. Walewski

Publication type:

Article

P1221: DIFFUSE LARGE B‐CELL LYMPHOMA RICHTER SYNDROME IN CHRONIC LYMPHOCYTIC LEUKEMIA – A RETROSPECTIVE ANALYSIS OF TREATMENT OUTCOMES IN POLISH ADULT LEUKEMIA STUDY GROUP.

Published in:

HemaSphere, 2022, v. 6, p. 1107, doi. 10.1097/01.HS9.0000847748.28786.05

By:

Sośnia, O.;
Danecki, M.;
Wąsik‐Szczepanek, E.;
Tryc‐Szponder, J.;
Iskierka‐Jażdżewska, E.;
Majeranowski, A.;
Pruszczyk, K.;
Krzemień, H.;
Bołkun, L.;
Paszkiewicz‐Kozik, E.;
Drozd‐Sokołowska, J.;
Kwiatkowski, J.;
Wiśniewska‐Organek, D.;
Budziszewska, B.;
Jamroziak, K.;
Hus, I.;
Lech‐Marańda, E.;
Puła, B.

Publication type:

Article

P677: CLINICAL EFFICACY AND TOLERABILITY OF VENETOCLAX PLUS RITUXIMAB IN RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA – REAL WORLD ANALYSIS OF POLISH ADULT LEUKEMIA STUDY GROUP.

Published in:

HemaSphere, 2022, v. 6, p. 575, doi. 10.1097/01.HS9.0000845592.42081.dc

By:

Soboń, A.;
Drozd‐Sokołowska, J.;
Paszkiewicz‐Kozik, E.;
Popławska, L.;
Morawska, M.;
Tryc‐Szponder, J.;
Bołkun, L.;
Rybka, J.;
Pruszczyk, K.;
Juda, A.;
Majeranowski, A.;
Iskierka‐Jażdżewska, E.;
Steckiewicz, P.;
Wdowiak, K.;
Budziszewska, B.;
Jamroziak, K.;
Hus, I.;
Lech‐Marańda, E.;
Puła, B.

Publication type:

Article

AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION FOR PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL). REAL‐WORLD REPORT OF POLISH LYMPHOMA RESEARCH GROUP.

Published in:

Hematological Oncology, 2023, v. 41, p. 691, doi. 10.1002/hon.3165_544

By:

Ostrowska, B.;
Domanska‐Czyz, K.;
Giza, A.;
Taszner, M.;
Romejko‐Jarosinska, J.;
Targonski, L.;
Poplawska, L.;
Konecki, R.;
Kotarska, M.;
Szymanski, M.;
Borawska, A.;
Swierkowska, M.;
Dabrowska‐Iwanicka, A.;
Druzd‐Sitek, A.;
Paszkiewicz‐Kozik, E.;
Mroz‐Zycinska, E.;
Osowiecki, M.;
Zimowska‐Curylo, D.;
Owczarek‐Kaczmarek, J.;
Tajer, J.

Publication type:

Article

CHARACTERISTICS AND TREATMENT OUTCOMES OF AGGRESSIVE HIGH GRADE B CELL LYMPHOMA WITH MYC AND BCL 6 REARRANGEMENTS.

Published in:

Hematological Oncology, 2023, v. 41, p. 651, doi. 10.1002/hon.3165_501

By:

Jarosinska, J. Romejko;
Rymkiewicz, G.;
Grygalewicz, B.;
Mroz‐Zycińska, E.;
Dabrowska‐Iwanicka, A.;
Blachnio, K.;
Bystydzienski, Z.;
Domanska‐Czyz, K.;
Ostrowska, B.;
Paszkiewicz‐Kozik, E.;
Borawska, A.;
Konecki, R.;
Targonski, L.;
Szymanski, M.;
Chmielewski, M.;
Walewski, J.

Publication type:

Article

A phase 2 study of zilovertamab vedotin as monotherapy or in combination in patients (pts) with aggressive and indolent B‐cell malignancies: waveLINE‐006.

Published in:

Hematological Oncology, 2023, v. 41, p. 564, doi. 10.1002/hon.3164_422

By:

Zinzani, P. L.;
Mayer, J.;
Benjamini, O.;
Berkovits, A.;
Glimelius, I.;
Stevens, D.;
Chaudhry, A.;
Demir, A. M.;
Sanz, R. G.;
Kim, W. S.;
Li, F.;
Halka, J.;
Marin‐Niebla, A.;
Ozcan, M.;
Paszkiewicz‐Kozik, E.;
Santoro, A.;
Ren, Y.;
Ogbu, U.;
Marinello, P.;
Jurczak, W.

Publication type:

Article

Outpatient treatment with 2 cycles of Bendamustine, Gemcitabine and Dexamethasone is Effective and Safe in r/r Hodgkin Lymphoma—Polish Lymphoma Research Group Study.

Published in:

Hematological Oncology, 2023, v. 41, p. 364, doi. 10.1002/hon.3164_262

By:

Paszkiewicz‐Kozik, E.;
Kurlapski, M.;
Swoboda, R.;
Subocz, E.;
Szymanski, M.;
Taszner, M.;
Wicherska‐Pawlowska, K.;
Koclega, A.;
Domanska‐Czyz, K.;
Swierkowska, M.;
Woszczyk, D.;
Targonski, L.;
Chmielowska, E.;
Dabrowska‐Iwanicka, A.;
Ostrowska, B.;
Romejko‐Jarosinska, J.;
Kotarska, M.;
Druzd‐Sitek, A.;
Konecki, R.;
Mroz‐Zycinska, E.

Publication type:

Article

WAVELINE‐004: OPEN‐LABEL, PHASE 2 STUDY OF ZILOVERTAMAB VEDOTIN (MK‐2140) IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL).

Published in:

Hematological Oncology, 2023, v. 41, p. 208, doi. 10.1002/hon.3163_136

By:

Fosså, A.;
Ozcan, M.;
Song, Y.;
Lee, S. T.;
Mensah, F.;
Modi, D.;
Kim, W. S.;
Paszkiewicz‐Kozik, E.;
Sawalha, Y.;
Sevindik, O. G.;
Norasetthada, L.;
Santoro, A.;
Pathiraja, K.;
Chakraborty, S.;
Marinello, P.;
Lavie, D.

Publication type:

Article

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE ERA OF NOVEL THERAPIES‐ A RETROSPECTIVE ANALYSIS BY POLISH LYMPHOMA RESEARCH GROUP.

Published in:

Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.24_2881

By:

Szlauer‐Stefańska, A. T;
Sawicki, W;
Paszkiewicz‐Kozik, E;
Romejko‐Jarosińska, J;
Czerw, T;
Giebel, S

Publication type:

Article

HEALTH‐RELATED QUALITY OF LIFE AMONG PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA (R/R CHL) IN A PHASE 3 STUDY OF PEMBROLIZUMAB VERSUS BRENTUXIMAB VEDOTIN.

Published in:

Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.105_2880

By:

Zinzani, P. L.;
Raut, M.;
Saretsky, T.;
Ramchandren, R.;
Santoro, A.;
Paszkiewicz‐Kozik, E.;
Gasiorowski, R.;
Johnson, N. A.;
de Oliveira, J. S. R.;
Buccheri, V.;
Perini, G. F.;
Dickinson, M.;
McDonald, A.;
Ozcan, M.;
Sekiguchi, N.;
Giezek, H.;
Nahar, A.;
Kuruvilla, J.

Publication type:

Article

PRIMARY BREAST DIFFUSE LARGE B‐CELL LYMPHOMA. CLINICAL FEATURES AND OUTCOME IN 55 PATIENTS. POLISH LYMPHOMA RESEARCH GROUP STUDY.

Published in:

Hematological Oncology, 2019, v. 37, p. 450, doi. 10.1002/hon.126_2631

By:

Romejko‐Jarosinska, J.;
Paszkiewicz‐Kozik, E.;
Sokołowska‐Drozd, J.;
Waszczuk‐Gajda, A.;
Kotarska, M.;
Blamek, S.;
Kulma‐Kreft, M.;
Kurczab, P.;
Kumiega, B.;
Sawczuk, W.;
Zaucha, J.;
Walewski, J.

Publication type:

Article

OFATUMUMAB WITH IVAC FOR DLBCL PATIENTS WHO FAILED R‐CHOP AND WERE NOT CANDIDATES FOR HIGH‐DOSE THERAPY AND ASCT ‐ PHASE 2 TRIAL OF THE POLISH LYMPHOMA RESEARCH GROUP (PLRG‐8).

Published in:

Hematological Oncology, 2019, v. 37, p. 436, doi. 10.1002/hon.111_2631

By:

Paszkiewicz‐Kozik, E.;
Michalski, W.;
Taszner, M.;
Knopińska‐Posłuszny, W.;
Mordak‐Domagała, M.;
Najda, J.;
Borawska, A.;
Romejko‐Jarosińska, J.;
Chełstowska, M.;
Świerkowska, M.;
Dąbrowska‐Iwanicka, A.;
Malenda, A.;
Druzd‐Sitek, A.;
Konecki, R.;
Kuniega, B.;
Osowiecki, M.;
Ostrowska, B.;
Szpila, T.;
Domańska‐Czyż, K.;
Szymański, M.

Publication type:

Article

OUTCOME OF PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMA WHO FAILED TO PROCEED TO OR RELAPSED AFTER HIGH DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION.

Published in:

Hematological Oncology, 2019, v. 37, p. 435, doi. 10.1002/hon.109_2631

By:

Romejko‐Jarosinska, J.;
Paszkiewicz‐Kozik, E.;
Popławska, L.;
Targonski, L.;
Szymanski, M.;
Walewski, J.

Publication type:

Article

PRIMARY BREAST DIFFUSE LARGE B‐CELL LYMPHOMA. CLINICAL FEATURES AND OUTCOME IN 55 PATIENTS. POLISH LYMPHOMA RESEARCH GROUP STUDY.

Published in:

Hematological Oncology, 2019, v. 37, p. 450, doi. 10.1002/hon.126_2631

By:

Romejko‐Jarosinska, J.;
Paszkiewicz‐Kozik, E.;
Sokołowska‐Drozd, J.;
Waszczuk‐Gajda, A.;
Kotarska, M.;
Blamek, S.;
Kulma‐Kreft, M.;
Kurczab, P.;
Kumiega, B.;
Sawczuk, W.;
Zaucha, J.;
Walewski, J.

Publication type:

Article

OFATUMUMAB WITH IVAC FOR DLBCL PATIENTS WHO FAILED R‐CHOP AND WERE NOT CANDIDATES FOR HIGH‐DOSE THERAPY AND ASCT ‐ PHASE 2 TRIAL OF THE POLISH LYMPHOMA RESEARCH GROUP (PLRG‐8).

Published in:

Hematological Oncology, 2019, v. 37, p. 436, doi. 10.1002/hon.111_2631

By:

Paszkiewicz‐Kozik, E.;
Michalski, W.;
Taszner, M.;
Knopińska‐Posłuszny, W.;
Mordak‐Domagała, M.;
Najda, J.;
Borawska, A.;
Romejko‐Jarosińska, J.;
Chełstowska, M.;
Świerkowska, M.;
Dąbrowska‐Iwanicka, A.;
Malenda, A.;
Druzd‐Sitek, A.;
Konecki, R.;
Kuniega, B.;
Osowiecki, M.;
Ostrowska, B.;
Szpila, T.;
Domańska‐Czyż, K.;
Szymański, M.

Publication type:

Article

OUTCOME OF PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMA WHO FAILED TO PROCEED TO OR RELAPSED AFTER HIGH DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION.

Published in:

Hematological Oncology, 2019, v. 37, p. 435, doi. 10.1002/hon.109_2631

By:

Romejko‐Jarosinska, J.;
Paszkiewicz‐Kozik, E.;
Popławska, L.;
Targonski, L.;
Szymanski, M.;
Walewski, J.

Publication type:

Article

THE RISK OF TRANSFORMATION OF FOLLICULAR LYMPHOMA 'TRANSFORMED' BY RITUXIMAB: THE ARISTOTLE STUDY PROMOTED BY THE EUROPEAN LYMPHOMA INSTITUTE.

Published in:

Hematological Oncology, 2017, v. 35, p. 115, doi. 10.1002/hon.2437_104

By:

Federico, M.;
Caballero, D.;
Marcheselli, L.;
Tarantino, V.;
Sarkozy, C.;
Lopez Guillermo, A.;
Wondergem, M.;
Kimby, E.;
Rusconi, C.;
Zucca, E.;
Montoto, S.;
Silva, M.G.;
Aurer, I.;
Paszkiewicz ‐ Kozik, E.;
Cartron, G.;
Morschhauser, F.;
Alcoceba, M.;
Chamuleau, M.;
Lockmer, S.;
Minoia, C.

Publication type:

Article

R-CHOP is not effective regimen in CD5(+) DLBCL diagnosed by flow-cytometry/immunohistochemistry, karyotype and BCL2/ BCL6 status and expression.

Published in:

Hematological Oncology, 2017, v. 35, p. 333, doi. 10.1002/hon.2439_78

By:

Rymkiewicz, G.;
Romejko ‐ Jarosinska, J.;
Paszkiewicz ‐ Kozik, E.;
Błachnio, K.;
Kotarska, M.;
Bystydzienski, Z.;
Domanska ‐ Czyz, K.;
Ostrowska, B.;
Dabrowska ‐ Iwanicka, A.;
Woroniecka, R.;
Grygalewicz, B.;
Osowiecki, M.;
Jastrzebska, A.;
Walewski, J.

Publication type:

Article

R- DAEPOCH as a first line treatment for high grade B cell lymphoma and diffuse large B cell lymphoma with unfavorable features.

Published in:

Hematological Oncology, 2017, v. 35, p. 335, doi. 10.1002/hon.2439_81

By:

Romejko ‐ Jarosinska, J.;
Rymkiewicz, G.;
Paszkiewicz ‐ Kozik, E.;
Dabrowska ‐ Iwanicka, A.P.;
Borawska, A.;
Domanska ‐ Czyz, K.;
Konecki, R.;
Kotarska, M.;
Osowiecki, M.;
Ostrowska, B.;
Poplawska, L.;
Swierkowska ‐ Czeneszew, M.;
Szymanski, M.;
Targonski, Ł.;
Blachnio, K.;
Bystydzienski, Z.;
Grygalewicz, B.;
Woroniecka, R.;
Walewski, J.

Publication type:

Article